BIOA
BioAge LabsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About BIOA
Bioage Labs, Inc.
A biotech company focused on assessing and optimizing biological age
5885 Hollis St, Suite 370, Emeryville, CA 94608
--
BioAge Labs, Inc., was incorporated in Delaware on April 1, 2015. They are a clinical-stage biopharmaceutical company developing product candidates for the treatment of metabolic diseases such as obesity by targeting the biology of human aging. Their technology platform and differentiated human datasets allow them to identify promising targets based on insights into the molecular changes that drive aging. Their main focus is metabolic disease, one of the biggest healthcare challenges in the world.
Company Financials
EPS
BIOA has released its 2025 Q3 earnings. EPS was reported at -0.56, versus the expected -0.51, missing expectations. The chart below visualizes how BIOA has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
BIOA has released its 2025 Q3 earnings report, with revenue of 2.05M, reflecting a YoY change of NaN%, and net profit of -20.17M, showing a YoY change of 13.82%. The Sankey diagram below clearly presents BIOA's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
